|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2007-7-19
|
|
pubmed:abstractText |
CD26 is a 110-kDa cell surface antigen with a role in tumor development. In this report, we show that CD26 is highly expressed on the cell surface of malignant mesothelioma and that a newly developed humanized anti-CD26 monoclonal antibody (mAb) has an inhibitory effect on malignant mesothelioma cells in both in vitro and in vivo experiments.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:DangNam HNH,
pubmed-author:HosonoOsamuO,
pubmed-author:InamotoSakikoS,
pubmed-author:InamotoTeruoT,
pubmed-author:KatsuokaYojiY,
pubmed-author:KinaShinichiroS,
pubmed-author:MorimotoChikaoC,
pubmed-author:OhnumaKeiK,
pubmed-author:TakahashiNozomuN,
pubmed-author:TanakaHirotoshiH,
pubmed-author:YamadaTaketoT,
pubmed-author:YamochiTadanoriT
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4191-200
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17634548-Antibodies, Monoclonal,
pubmed-meshheading:17634548-Antigens, CD,
pubmed-meshheading:17634548-Dipeptidyl Peptidase 4,
pubmed-meshheading:17634548-Humans,
pubmed-meshheading:17634548-Immunity, Cellular,
pubmed-meshheading:17634548-Immunohistochemistry,
pubmed-meshheading:17634548-Immunotherapy,
pubmed-meshheading:17634548-Lung Neoplasms,
pubmed-meshheading:17634548-Mesothelioma,
pubmed-meshheading:17634548-Tumor Cells, Cultured
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors.
|
|
pubmed:affiliation |
Division of Clinical Immunology, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
